Tag: Ruxolitinib

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Ruxolitinib

UVA Discovery Suggests Potential New Treatment for Deadly Blood Cancer

Added to Collection on: 2021-08-11 11:15:00

Tags for this article:

Chemical compounds
Organic compounds
Branches of biology
Cyclopentanes
Primary myelofibrosis
Palbociclib
Ruxolitinib
Leukemia
Bone marrow
Splenomegaly
Myeloproliferative neoplasm

Click the tags to see associated articles and topics

View Article Details
CTI BioPharma: A Speculative Buy Into The PDUFA Date (NASDAQ:CTIC) | Seeking Alpha

Added to Collection on: 2022-03-01 07:30:56

Tags for this article:

Chemical compounds
Food and Drug Administration
Health
Organic compounds
Nitriles
Orphan drugs
Primary myelofibrosis
Prescription Drug User Fee Act
Ruxolitinib
PDUFA date
pacritinib
Priority review
CTi Biopharma

Click the tags to see associated articles and topics

View Article Details
Recap: Treatment Advances in Chronic GVHD - Cancer Network

Added to Collection on: 2022-05-15 18:04:26

Tags for this article:

Bristol-Myers Squibb
Abatacept
Immunosuppressants
Improvement
Ruxolitinib

Click the tags to see associated articles and topics

View Article Details
FDA approves topical treatment addressing repigmentation in vitiligo in patients aged 12 and older

Added to Collection on: 2022-07-19 18:06:24

Tags for this article:

Chemical compounds
Autoimmune diseases
Vitiligo
Biology
Organ systems
Janus kinase inhibitor
Depigmentation
Ruxolitinib
World Vitiligo Day
Hypopigmentation

Click the tags to see associated articles and topics

View Article Details
FDA approves ruxolitinib cream 1.5% to treat nonsegmental vitiligo

Added to Collection on: 2022-07-19 15:24:13

Tags for this article:

Chemical compounds
Life Sciences
Organ systems
Autoimmune diseases
Janus kinase inhibitor
Vitiligo
Ruxolitinib
Incyte
Depigmentation
Dermatology
United States

Click the tags to see associated articles and topics

View Article Details
Role of JAK Inhibitors in Vitiligo Treatment - Managed Healthcare Executive

Added to Collection on: 2022-10-01 04:55:51

Tags for this article:

Chemical compounds
Medicine
Clinical medicine
RTT
Autoimmune diseases
Psoriasis
Light therapy
Neonatology
Vitiligo
Depigmentation
Ruxolitinib
Monobenzone

Click the tags to see associated articles and topics

View Article Details
Rampal Reviews Data for First-line Therapy in Myelofibrosis With High Platelet Count

Added to Collection on: 2022-11-13 00:10:09

Tags for this article:

Chemical compounds
Blood
Branches of biology
Pyrazoles
Cyclopentanes
Nitriles
Ruxolitinib
Transfusion medicine
Myelofibrosis
Platelet

Click the tags to see associated articles and topics

View Article Details
Opna Bio Launches With $38M Series A Financing | Precision Oncology News

Added to Collection on: 2022-11-23 07:09:15

Tags for this article:

Medicine
Organ systems
Medical specialties
Immune system
FMR1
Checkpoint inhibitor
Ruxolitinib
Cancer immunotherapy
Fragile X syndrome
Immune checkpoint
Menlo Ventures

Click the tags to see associated articles and topics

View Article Details
Sumitomo Pharma Oncology Presents Preliminary Data from Phase 1/2 Clinical Study ...

Added to Collection on: 2022-12-10 23:13:53

Tags for this article:

Chemical compounds
Pyrazoles
Cancer
Myelofibrosis
PIM1
Ruxolitinib
Janus kinase inhibitor
Janus kinase 2
Oncology
Sumitomo Pharma Oncology Inc.

Click the tags to see associated articles and topics

View Article Details
Incyte shares drop after FDA approves GSK's competing blood-cancer treatment

Added to Collection on: 2023-09-18 12:17:49

Tags for this article:

Financial data vendors
Primary myelofibrosis
Incyte
Ruxolitinib
Dow Jones & Company
Polycythemia vera
The Wall Street Journal
Incyte Corp

Click the tags to see associated articles and topics

View Article Details